Lithium Therapy Guidelines

Initial Dosing and Monitoring

• For elderly patients, the American Academy of Family Physicians recommends using lower starting doses (150 mg/day) due to increased sensitivity to lithium and reduced clearance 1
• Baseline laboratory tests should include complete blood count 1, thyroid function tests (TSH, free T4) 2, renal function (blood urea nitrogen, creatinine, GFR) 2, serum electrolytes including calcium 3, and urinalysis 4
• The American Journal of Kidney Diseases recommends assessing for contraindications, including significant renal impairment 3, cardiovascular disease 4, severe dehydration 4, and sodium depletion 4

Dosage Adjustments and Special Considerations

• For patients with GFR < 60 ml/min/1.73 m², the American Journal of Kidney Diseases suggests considering lower doses and more frequent monitoring 4, 3
• The American Journal of Kidney Diseases recommends reducing dose by 50% in patients with GFR < 30 ml/min/1.73 m² 2
• Concomitant use of NSAIDs should be avoided as they can increase lithium levels and risk of toxicity 4, 3
• Maintaining adequate hydration is crucial, especially during intercurrent illness 4, 3

Guidelines for Increasing Lithium Dose

Target Serum Levels and Dose Adjustments

• When lithium is used to augment antidepressants, lower blood levels (0.2-0.6 mEq/L) may be adequate, as recommended by the American Academy of Family Physicians 5

Lithium Toxicity and Monitoring

Introduction to Lithium Therapy

• The FDA emphasizes that lithium toxicity is closely related to serum concentrations and can occur at doses close to therapeutic levels, with toxicity risk beginning at 1.5 mEq/L and serious toxicity at >2.0 mEq/L 6, 7, 8

Monitoring and Maintenance

• During the acute phase of lithium treatment, serum concentrations should be checked twice per week until levels and clinical condition stabilize, according to guidelines from the American Academy of Sleep Medicine 6, 7, 8

Lithium Therapy Monitoring Guidelines

Prerequisites for Initiation

• Lithium should only be initiated in settings where personnel and facilities for close clinical monitoring are available, routine laboratory monitoring is accessible, particularly in low-resource settings 9

Factors Affecting Lithium Levels

• The American Academy of Child and Adolescent Psychiatry was not found to have any relevant information in this article, however, other sources suggest that medications such as NSAIDs can increase lithium levels and risk of toxicity, and concomitant use should be avoided whenever possible, although no specific citation was provided in the article for this fact, a similar fact was mentioned with regards to the initiation of lithium therapy 9

Gastric Decontamination in Lithium Toxicity

Activated Charcoal

• Activated charcoal does not bind lithium and therefore should not be used for gastric decontamination in patients with moderate‑to‑severe lithium toxicity (e.g., confusion, seizures, coma)【10】.

Cardiovascular and Gastrointestinal Assessment in Severe Lithium Toxicity

Cardiovascular Monitoring

• Severe lithium toxicity (serum level ≈ 2.9 mEq/L) warrants evaluation of cardiovascular status, specifically for the presence of arrhythmias and hypotension, as these are common acute complications 11.

Gastrointestinal Evaluation

• Patients with severe lithium toxicity should be assessed for gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which frequently accompany the toxic presentation 11.

Hydration Management and Dehydration Warning Signs in Lithium Therapy

Fluid Adjustment Recommendations

• Patients receiving lithium should increase their daily fluid intake by 0.5–1 L during hot weather or heat exposure, in addition to the standard 2.5–3 L, to compensate for sweat‑related losses and maintain stable lithium levels. 12

Dehydration‑Related Warning Signs

• The appearance of dehydration‑related symptoms—including fatigue, reduced urine output, dizziness, muscle weakness, diarrhea, vomiting, or excessive sweating—indicates decreased lithium clearance and a heightened risk of toxicity; these signs require immediate medical evaluation. 12